Raaj Medisafe India (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Raaj Medisafe India Limited |
|||
|
Price: ₹72.02 (-3.97%) | ||
| 52 Week Low: ₹46.20 52 Week High: ₹122.60 |
|||
| Market Capital: 35.78 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Raaj Medisafe India Share Price Target For 2025
- 1.1.1: Raaj Medisafe India Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Raaj Medisafe India Share Price Target For 2026
- 1.2.1: Raaj Medisafe India Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Raaj Medisafe India Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Raaj Medisafe India Financial Performance
- 3.0.1: Is Raaj Medisafe India A Good Buy For Long Term?
Raaj Medisafe India, a Small Cap company has delivered 644.8% returns in 5-year with 25.0% profit margin, making it a potential Multibagger.
To predict the Raaj Medisafe India's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Raaj Medisafe India Share Price Target For 2025
The line chart displays the monthly closing prices of Raaj Medisafe India with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Raaj Medisafe India shares in 2025, see the table below.
Raaj Medisafe India Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 86.01 (+19.42%) | Price Action: 21 Nov 2024 High |
| 2025 Target 2 | 85.0 (+18.02%) | Price Action: 29 Nov 2024 High |
| 2025 Target 1 | 84.0 (+16.63%) | Price Action: 30 Dec 2024 Low |
| Current Price | 72.02 | Raaj Medisafe India's share price as of 13 Jan 2025 |
| Stop Loss 1 | 65.0 (-9.75%) | Price Action: 06 Mar 2024 High |
| Stop Loss 2 | 64.1 (-11%) | Price Action: 10 May 2024 High |
| Stop Loss 3 | 62.61 (-13.07%) | Price Action: 06 Mar 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Raaj Medisafe India is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹84.92 serves as the nearest technical reference point.
Historical Returns: 3-month: -24.59% | 6-month: -33.61% | 1-year: +46.83%
Raaj Medisafe India Share Price Target For 2026
The line chart displays the monthly closing prices of Raaj Medisafe India with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Raaj Medisafe India shares in 2026, see the table below.
Raaj Medisafe India Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 140.46 (+95.02%) | Price Action: Chart |
| 2026 Target 2 | 137.84 (+91.39%) | Price Action: Chart |
| 2026 Target 1 | 136.48 (+89.5%) | Fibonacci Extension Level 64.90% |
| Current Price | 72.02 | Raaj Medisafe India's share price as of 13 Jan 2025 |
| Stop Loss 1 | 57.24 (-20.53%) | Price Action: 18 Jan 2024 High |
| Stop Loss 2 | 56.52 (-21.53%) | Price Action: 29 Feb 2024 High |
| Stop Loss 3 | 55.93 (-22.35%) | Price Action: 06 May 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Raaj Medisafe India is currently trading at 33.8% of its 52-week range (₹46.2 - ₹122.6).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +46.83% | 3-year: +92.31% | 5-year: +644.78%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Raaj Medisafe India Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹72.02 | ||
| 2025 | ₹124.00 | +72.17% | ₹125.86 |
| 2026 | ₹187.60 | +51.29% | ₹190.41 |
| 2027 | ₹281.84 | +50.23% | ₹286.07 |
| 2028 | ₹392.19 | +39.15% | ₹398.07 |
| 2029 | ₹538.84 | +37.39% | ₹546.92 |
| 2030 | ₹742.15 | +37.73% | ₹753.28 |
| 2031 | ₹1,061.78 | +43.06% | ₹1,077.71 |
| 2032 | ₹1,474.26 | +38.84% | ₹1,496.37 |
| 2033 | ₹1,865.23 | +26.51% | ₹1,893.21 |
| 2034 | ₹2,429.56 | +30.25% | ₹2,466.00 |
| 2035 | ₹2,991.48 | +23.12% | ₹3,036.35 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Raaj Medisafe India Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 35.78 Crore | Market valuation of Raaj Medisafe India's shares. |
| Revenue (TTM) | 38.62 Crore | Total revenue generated by Raaj Medisafe India over the past twelve months. |
| Net Income (TTM) | +3.32 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.5% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +24.97% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-9.18% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
1.74 | Company's total debt divided by total shareholder equity. |
| Total Debt | 15.97 Crore | Sum of Raaj Medisafe India's current & long-term financial obligations. |
Is Raaj Medisafe India A Good Buy For Long Term?
With a consistent revenue growth in the past and impressive returns over various time frames, Raaj Medisafe India appears to be a promising investment option. Its strong revenue generation, coupled with a healthy profit margin, suggests financial stability. Despite its debt, the company's financial performance remains positive, making it an average buy for long-term investors seeking growth potential.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
